G Ogg

Author PubWeight™ 42.61‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997 12.26
2 Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J Exp Med 2001 6.51
3 Functionally inert HIV-specific cytotoxic T lymphocytes do not play a major role in chronically infected adults and children. J Exp Med 2000 2.31
4 Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 2000 1.71
5 Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection. Proc Natl Acad Sci U S A 1996 1.68
6 Pathogenesis of severe dengue infection. Ceylon Med J 2012 1.49
7 T cells reactive with the NC16A domain of BP180 are present in vulval lichen sclerosus and lichen planus. J Eur Acad Dermatol Venereol 2009 1.46
8 Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors. J Immunol Methods 1997 1.39
9 Cellular and humoral antigenic epitopes in HIV and SIV. Immunology 1992 1.38
10 Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors. Immunol Lett 1999 1.32
11 Memory CD8+ T cells in HIV infection. Philos Trans R Soc Lond B Biol Sci 2000 1.15
12 Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J Immunol 1999 0.98
13 Stability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparison to class I proteins. Proc Natl Acad Sci U S A 1997 0.95
14 An antigenic threshold for maintaining human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. Mol Med 2000 0.94
15 The dynamics of the cellular immune response to HIV infection: implications for vaccination. Philos Trans R Soc Lond B Biol Sci 2000 0.92
16 Vancomycin-induced linear IgA disease with autoantibodies to BP180 and LAD285. Br J Dermatol 2001 0.88
17 Anti-HLA-A2 antibody-enhancement of peptide association with HLA-A2 as detected by cytotoxic T lymphocytes. Nature 1989 0.86
18 Induction of viral and tumour specific CTL responses using antibody targeted HLA class I peptide complexes. Br J Cancer 2002 0.83
19 Identification of serotype-specific T cell responses to highly conserved regions of the dengue viruses. Clin Exp Immunol 2012 0.81
20 Defining the T cell antigen proteome of wasp venom. Clin Exp Allergy 2006 0.79
21 Molecular characterisation of varicella zoster virus genotypes in Sri Lanka. Ceylon Med J 2013 0.76
22 Filaggrin null mutations associate with increased frequencies of allergen-specific CD4+ T-helper 2 cells in patients with atopic eczema. Br J Dermatol 2010 0.76
23 HIV clearance in infants. Lancet 1996 0.75
24 Spontaneous resolution of basal cell carcinoma in naevoid basal cell carcinoma syndrome/Gorlin's syndrome. Clin Exp Dermatol 2009 0.75
25 Acetylator phenotype, nitrazepam plasma concentrations and residual effects [proceedings]. Br J Clin Pharmacol 1980 0.75
26 Frequencies of circulating allergen-specific T cells temporally associate with longitudinal changes in severity of cutaneous atopic disease. Clin Exp Dermatol 2010 0.75